Mycobacterium tuberculosis complex
GPTKB entity
Statements (63)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:research_center
|
gptkbp:affects |
gptkb:humans
|
gptkbp:antigenic_variation |
limited antigenic variation
|
gptkbp:cause |
tuberculosis
|
gptkbp:controls |
directly observed therapy
|
gptkbp:culture_medium |
gptkb:Lowenstein-Jensen_medium
|
gptkbp:diagnosis |
chest X-ray
tuberculin skin test interferon-gamma release assays |
gptkbp:discovery |
gptkb:Robert_Koch
|
gptkbp:diseases |
extrapulmonary tuberculosis
intracellular pathogen latent tuberculosis infection |
gptkbp:duration |
6 to 9 months
|
gptkbp:epidemiology |
public health concern
|
gptkbp:first_described_by |
1882
|
gptkbp:genetic_diversity |
clonal expansion
high genetic variability |
gptkbp:geographic_distribution |
worldwide
|
gptkbp:global_burden |
millions of cases annually
significant mortality rate |
gptkbp:has_features |
positive
|
gptkbp:hosts |
gptkb:humans
|
https://www.w3.org/2000/01/rdf-schema#label |
Mycobacterium tuberculosis complex
|
gptkbp:includes |
gptkb:Mycobacterium_africanum
gptkb:Mycobacterium_bovis gptkb:Mycobacterium_tuberculosis Mycobacterium canettii Mycobacterium microti |
gptkbp:is_monitored_by |
mandatory reporting in many countries
|
gptkbp:is_vulnerable_to |
limited in adults
approximately 70% in children |
gptkbp:prevention |
BCG vaccine
|
gptkbp:provides_guidance_on |
combination therapy
first-line drugs second-line drugs |
gptkbp:public_health_strategy |
education and awareness
contact tracing screening programs |
gptkbp:research_focus |
diagnostic tests
vaccine development understanding resistance mechanisms new antibiotics |
gptkbp:risk_factor |
gptkb:diabetes
malnutrition smoking immunosuppression HIV infection |
gptkbp:seed_dispersal |
approximately 4.4 million base pairs
|
gptkbp:symptoms |
weight loss
fever night sweats chronic cough |
gptkbp:transmission |
airborne droplets
|
gptkbp:treatment |
treatment adherence
antibiotics drug resistance cure rate with proper treatment relapse possible after treatment |
gptkbp:virulence_factor |
mycolic acids
cord factor |
gptkbp:water_requirement |
aerobic
|
gptkbp:water_resistance |
multi-drug resistant tuberculosis
|